(Q34004162)

30 July 2017

1 reference

title

Treatment of patients hospitalized for psoriasis (English)

1 reference

30 July 2017

1 reference

Prodanovich S

1

1 reference

PubMed ID

10943538

30 July 2017

Kirsner RS

series ordinal

2

1 reference

PubMed ID

10943538

30 July 2017

Taylor JR

series ordinal

3

1 reference

30 July 2017

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

18

1 reference

30 July 2017

3

1 reference

30 July 2017

425-35, viii

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

30 July 2017

1 reference

7 January 2021

Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Anthralin: historical and current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Altered cell-mediated immunity to group A haemolytic streptococcal antigens in chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

GENERALIZED PUSTULAR PSORIASIS

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Corticosteroids and pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Letter: HL-A histocompatibility and cadaver kidney-graft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

White paper on hospitalization for psoriasis care

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

A Topical Treatment Program for Psoriasis with Low Anthralin Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Onset of psoriasis at age 108

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Ingram method of treating psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Effects of cyclosporine on immunologic mechanisms in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Photosensitivity due to pitch

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Psoriasis: improvement during and worsening after pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

A double-blind evaluation of topical capsaicin in pruritic psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Hospital treatment of psoriasis. A modified anthralin program

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Psoriasis-an index of disability

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Topical Antipsoriatic Agents and Epidermal Mitosis in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The Effect of Coal Tar Distillate, Cadmium Sulfide, Ichthyol Sodium and Omadine MDS on the Epidermis of the Guinea Pig

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Recent advances in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

A case of AIDS manifesting pruritic papular eruptions and psoriasiform lesions: an immunohistochemical study of the lesional dermal infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The approach to psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The mode of inheritance of psoriasis: evidence for a major gene as well as a multifactorial component and its implication for genetic counselling

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Effects of anthralin and analogues on growth and [3H] thymidine incorporation in human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The T4 lymphocyte in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Histocompatibility antigens: a laboratory and epidemiologic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

HL-A antigen in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Methotrexate in childhood psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The atrophogenic effect of crude coal tar on human epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Staphylococcus aureus in the lesions of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Severe osteolytic arthritis mutilans in pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

1 reference

7 January 2021

Cross-reactivity between streptococcal M surface antigen and human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Successful treatment of generalized pustular psoriasis (von Zumbusch) by systemic antibiotics controlled by blood culture

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Physicochemical properties and stability of anthralin in model systems and human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Class II MHC molecules are specific receptors for staphylococcus enterotoxin A

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Anthralin-Corticosteroid Combination Therapy in the Treatment of Chronic Plaque Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

CD4 antibody treatment of severe psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Palmoplantar pustulosis and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Generalized pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Ingram method: the precursor of photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Research needs in 11 major areas in dermatology. I. Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Histocompatibility (HL-A) Antigens Associated with Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Relapse rate of psoriasis worsened by adding steroids to a dithranol regime

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Interferon Gamma-Treated Keratinocytes Activate T Cells in the Presence of Superantigens: Involvement of Major Histocompatibility Complex Class II Molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

1 reference

7 January 2021

Tar Phototoxicity and Phototherapy for Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

The Role of Streptococcal Infection in the Initiation of Guttate Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Immunointervention in psoriasis with anti-CD4 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Pustulosis palmaris et plantaris

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Psoriasis und pustulöses Exanthem

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Oligaemia, Renal Failure, and Jaundice Associated with Acute Pustular Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Disturbance of HL-A Antigen Frequency in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Palmoplantar pustular psoriasis provoked by lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Experimental contribution to the dithranol-brown problem

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

Scale prophylaxis. A new antiparakeratotic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970191-1

7 January 2021

10.1016/S0733-8635(05)70191-1

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10943538